Cargando…
Acute Liver Failure Secondary to Remdesivir in the Treatment of COVID-19
Remdesivir has been the mainstay of coronavirus disease 2019 treatment since the start of the severe acute respiratory syndrome coronavirus 2 pandemic. Despite its growing use, safety data are limited. We present the case of an elderly man with obesity and coronavirus disease 2019 who developed acut...
Autores principales: | Lin, Kevin, Gausman, Valerie, Poles, Michael, Popov, Violeta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534366/ https://www.ncbi.nlm.nih.gov/pubmed/36212242 http://dx.doi.org/10.14309/crj.0000000000000866 |
Ejemplares similares
-
Remdesivir: Acute liver failure and encephalopathy: case report
Publicado: (2021) -
Remdesivir: Acute renal failure: case report
Publicado: (2022) -
Remdesivir-Associated Acute Liver Failure in a COVID-19 Patient: A Case Report and Literature Review
por: Ahmed-Khan, Mohammad A, et al.
Publicado: (2023) -
Treatment of Severe COVID-19 Infection With Remdesivir in Peritoneal Dialysis
por: Geffin, Ryan, et al.
Publicado: (2023) -
Remdesivir-induced symptomatic bradycardia in the treatment of COVID-19 disease
por: Jacinto, Jomel Patrick, et al.
Publicado: (2021)